Patents by Inventor Haby HENARY

Haby HENARY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY OF KRAS INHIBITOR AND SHP2 INHIBITOR FOR TREATMENT OF CANCERS
    Publication number: 20240139193
    Abstract: Provided herein are methods of administering a KRAS G12C inhibitor in combination with a SHP2 inhibitor to a cancer subject.
    Type: Application
    Filed: October 14, 2020
    Publication date: May 2, 2024
    Inventors: Haby HENARY, James Russell LIPFORD
  • USE OF KRAS G12C INHIBITOR IN TREATING CANCERS
    Publication number: 20240091230
    Abstract: The present disclosure provides uses for a KRASG12C inhibitor, such as the compound of Formula I (AMG 510, sotorasib) in treating cancers, such as non-small cell lung cancer, in subjects with certain characteristics.
    Type: Application
    Filed: January 7, 2022
    Publication date: March 21, 2024
    Inventors: Agnes L. ANG, Haby HENARY, Gataree NGARMCHAMNANRITH
  • DOSING REGIMEN OF KRAS G12C INHIBITOR
    Publication number: 20240082251
    Abstract: Provided herein are methods of administering a KRAS G12C inhibitor to a cancer subject.
    Type: Application
    Filed: November 6, 2023
    Publication date: March 14, 2024
    Inventors: Haby HENARY, James Russell LIPFORD, Victor J. CEE
  • DOSING REGIMEN OF KRAS G12C INHIBITOR
    Publication number: 20230248729
    Abstract: Provided herein are methods of administering a KRAS G12C inhibitor to a cancer subject.
    Type: Application
    Filed: April 21, 2023
    Publication date: August 10, 2023
    Inventors: Haby HENARY, James Russell LIPFORD, Victor J. CEE
  • DOSING REGIMEN OF KRAS G12C INHIBITOR
    Publication number: 20230028414
    Abstract: Provided herein are methods of administering a KRAS G12C inhibitor to a cancer subject.
    Type: Application
    Filed: December 15, 2020
    Publication date: January 26, 2023
    Inventors: Haby HENARY, James Russell LIPFORD, Victor J. CEE
  • DOSING OF KRAS INHIBITOR FOR TREATMENT OF CANCERS
    Publication number: 20220378787
    Abstract: Provided herein are methods of administering a KRAS G12C inhibitor to a cancer subject.
    Type: Application
    Filed: July 22, 2022
    Publication date: December 1, 2022
    Applicant: Amgen Inc.
    Inventors: Haby HENARY, James Russell LIPFORD, VIctor J. CEE
  • SOTORASIB DOSING REGIMEN
    Publication number: 20220323446
    Abstract: Provided herein are methods of treating cancer in a patient comprising administering a total daily dose of 240 mg sotorasib to the patient, wherein the cancer is a KRAS G12C mutated cancer. Also provided herein are methods of treating KRAS G12C mutated cancer in a patient comprising administering a total daily dose of 960 mg sotorasib to the patient, and reducing the total daily dose of sotorasib to 480 mg in a patient experiencing an adverse event to the 960 mg dose of sotorasib.
    Type: Application
    Filed: March 16, 2022
    Publication date: October 13, 2022
    Inventors: Gregory FRIBERG, Haby HENARY, Brett E. HOUK, Omar A. MATHER, Gataree NGARMCHAMNANRITH, Sandeep DUTTA
  • Dosing of inhibitor for treatment of cancers
    Patent number: 11426404
    Abstract: Provided herein are methods of administering a KRAS G12C inhibitor to a cancer subject.
    Type: Grant
    Filed: May 13, 2020
    Date of Patent: August 30, 2022
    Assignee: Amgen Inc.
    Inventors: Haby Henary, James Russell Lipford, Victor J. Cee
  • DOSING OF KRAS INHIBITOR FOR TREATMENT OF CANCERS
    Publication number: 20200360374
    Abstract: Provided herein are methods of administering a KRAS G12C inhibitor to a cancer subject.
    Type: Application
    Filed: May 13, 2020
    Publication date: November 19, 2020
    Applicant: AMGEN INC.
    Inventors: Haby HENARY, James Russell LIPFORD, Victor J. CEE